Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2010-03-02

FDA Approved: FEMARA — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

The FDA approved a supplemental application for Femara (letrozole) submitted by Novartis Pharmaceuticals Corporation. This approval updates the product labeling…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FEMARA (letrozole)

Snippet

SUPPL AP for FEMARA (LETROZOLE)